Oppimi Group and Oppimi China are proud to announced a three-year research partnership with Beijing Union university to unlock the potential of digital therapeutics in dyslogographia, dysgraphia applied to Chinese characters.
The Data Science Research Partnership will be at the forefront of machine learning in the digital health industry, helping create modern tools that can efficiently support learning disabilities specialists diagnosing, identifying and treating affected children.
The partnership brings together China expert Professor Mao from Beijing University and world-leading experts from Oppimi Team to better understand dyslogographia.
The partnership is adding to the actual network of universities and clinics Oppimi is building worldwide including University of Parma, Italy and Vimercate Hospital. The aim is to create an international body of research, insights and prototypes that can continue making a real impact on young population as well as on education.
Understanding specificity of Chinese dyslogographia, this will bring our machine learning to an universalised structure that unlock further discoveries on dysgraphia,
Understanding correlation of social elements into detection and diagnosis for Chinese populations and specific groups,
Define the first Assessment Scale for Chinese Handwriting.
Alongside this will be a range of educational opportunities to help the Beijing University and its staff improve the skills they’ll need in a data-driven future.
Ervin Ukaj, Oppimi’s President and CEO, says: “Oppimi has always been at its best when it combines science with technology. As we reinvent the screening and treatment of learning disabilities, we can see the opportunities that data and machine learning are opening up for us, the scientific community and the children. This partnership will help us break new ground and ensure we are giving children the very best in digital therapeutics toward learning disabilities.”